Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,108,000 | 1,573,800 | 1,548,100 | 1,169,500 | 924,000 |
| Marketable Securities | 1,808,000 | 2,115,200 | 1,960,200 | 1,723,500 | 1,956,200 |
| Receivables | 1,939,200 | 1,787,000 | 1,567,500 | 1,630,200 | 1,501,500 |
| Inventories | 906,600 | 902,700 | 1,007,200 | 936,500 | 921,600 |
| Other current assets | 1,433,600 | 1,494,600 | 1,485,000 | 1,649,000 | 1,556,400 |
| TOTAL | $10,195,400 | $7,873,300 | $7,568,000 | $7,108,700 | $6,859,700 |
| Non-Current Assets | |||||
| PPE Net | 3,334,700 | 3,182,400 | 2,995,900 | 2,827,600 | 2,610,900 |
| Investments And Advances | 1,580,300 | 3,488,900 | 4,362,400 | 3,901,000 | 4,009,700 |
| Intangibles | 8,702,300 | 8,512,100 | 8,146,900 | 7,921,700 | 7,715,600 |
| Other Non-Current Assets | 2,277,400 | 595,900 | 0 | 0 | 0 |
| TOTAL | $15,894,700 | $15,779,300 | $15,505,200 | $14,650,300 | $14,336,200 |
| Total Assets | $26,090,100 | $23,652,600 | $23,073,200 | $21,759,000 | $21,195,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 345,800 | 395,500 | 298,700 | 330,300 | 316,400 |
| Accrued Expenses | 2,571,100 | 2,901,300 | 2,455,200 | 2,436,900 | 2,044,600 |
| TOTAL | $3,152,100 | $3,368,200 | $3,448,400 | $3,379,700 | $2,992,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,929,400 | 5,935,000 | 5,938,300 | 5,954,000 | 5,952,700 |
| Other Non-Current Liabilities | 1,641,700 | 1,497,600 | 716,900 | 750,900 | 688,900 |
| TOTAL | $8,900,500 | $7,686,300 | $6,775,900 | $6,805,700 | $6,736,000 |
| Total Liabilities | $12,052,600 | $11,054,500 | $10,224,300 | $10,185,400 | $9,728,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 211,008 | 211,563 | 211,477 | 211,432 | 212,115 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 17,334,600 | 15,810,400 | 16,107,700 | 14,881,700 | 14,781,200 |
| Other shareholders' equity | -320,200 | -333,200 | -341,100 | -350,500 | -336,900 |
| TOTAL | $14,037,500 | $12,598,100 | $12,848,900 | $11,573,600 | $11,467,400 |
| Total Liabilities And Equity | $26,090,100 | $23,652,600 | $23,073,200 | $21,759,000 | $21,195,900 |